VIVANI MEDICAL, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.28 USD | +4.07% |
|
-3.76% | +25.49% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Companyâs lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight management and patients with type 2 diabetes, respectively. Its other pipeline product candidates include NPM-139, and OKV-119. It uses this platform technology to develop and commercialize drug implant candidates for the treatment of chronic disease and medication non-adherence. It operates through two segments: Biopharm Division and Neuromodulation Division. The Companyâs implant technology, which it refers as NanoPortal, utilizes a space-efficient design that allows a miniaturized implant to provide many months of therapeutic delivery of potent molecules.
Calendar
27/06/2024
- Annual General Meeting
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.28
USD
Average target price
8
USD
Spread / Average Target
+525.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.49% | 7.04Cr | |
| +13.72% | 13TCr | |
| -9.24% | 1.08TCr | |
| -15.31% | 711.6Cr | |
| +45.02% | 566.37Cr | |
| -32.16% | 414.17Cr | |
| +7.91% | 345.91Cr | |
| -19.87% | 246.83Cr | |
| -17.06% | 195Cr | |
| -22.28% | 169.5Cr |
- Stock Market
- Equities
- VANI Stock
- News Vivani Medical, Inc.
- Vivani Medical Prices $15 Million Registered Direct Offering; Shares Slump
